Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Leases (2019 - 2025)

Iradimed has reported Current Leases over the past 7 years, most recently at $59221.0 for Q1 2025.

  • Quarterly Current Leases fell 85.86% to $59221.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $59221.0 through Mar 2025, down 85.86% year-over-year, with the annual reading at $153264.0 for FY2024, 64.19% down from the prior year.
  • Current Leases was $59221.0 for Q1 2025 at Iradimed, down from $153264.0 in the prior quarter.
  • Over five years, Current Leases peaked at $427963.0 in Q4 2023 and troughed at $59221.0 in Q1 2025.
  • The 5-year median for Current Leases is $284891.0 (2022), against an average of $303403.1.
  • Year-over-year, Current Leases surged 45.83% in 2023 and then crashed 85.86% in 2025.
  • A 5-year view of Current Leases shows it stood at $276568.0 in 2021, then grew by 6.11% to $293466.0 in 2022, then surged by 45.83% to $427963.0 in 2023, then crashed by 64.19% to $153264.0 in 2024, then tumbled by 61.36% to $59221.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Current Leases are $59221.0 (Q1 2025), $153264.0 (Q4 2024), and $261244.0 (Q3 2024).